Treatment of Severe Childhood Aggression (The TOSCA Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Methylphenidate HCl

"For children weighing less than 25 kg, the dose will be titrated at 18 mg for the first 7 days, 36 mg for the next 4 days, and, if needed, 54 mg for the next 4 days. For children weighing more than 25 kg, the dose will be titrated at 18 mg for the first 4 days, 36 mg for the next 3 days, 54 mg for the next 4 days, and 72 mg for the next 3 days.~Once the child's optimal dose is established, he or she will continue on that dose for the rest of the 21-week trial.~One pill is taken once daily."

DRUG

Risperidone

"For children weighing less than 45 kg, the dose will start at 0.5 mg at night. After 4 days, the child's dose may be increased to 1 mg a day. On Day 8, the child's dose may be increased to 1.5 mg a day. On Day 16, the child's dose may be increased to 2.0 mg a day. On Day 22, the child's dose may be increased to 2.5 mg a day.~For children weighing more than 45 kg, the dose will start at 0.5 mg at night. After 4 days, the child's dose may be increased to 1.0 mg a day. On Day 8, the child's dose may be increased to 1.5 mg a day. On Day 12, the child's dose may be increased to 2.0 mg a day. On Day 15, the child's dose may be increased to 2.5 mg a day. On Day 18, the child's dose may be increased to 3 mg a day. On Day 23, the child's dose may be increased to 3.5 mg a day."

BEHAVIORAL

Parent Management Training (PMT)

PMT will include individual parent sessions held weekly for 9 weeks, with two booster sessions to be completed during the 3-month extension. Sessions will include development of problem-solving skills and behavior management strategies, practice activities, and role-playing with the behavioral therapist.

DRUG

Placebo

One pill will be taken once daily for the first 4 days and then twice daily until Week 21.

Trial Locations (4)

11794

State University of New York Stony Brook, Stony Brook

15213

University of Pittsburgh, Pittsburgh

43210

Ohio State University Nisonger Center, Columbus

44106

Case Western Reserve University, Cleveland

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Michael Aman

OTHER

NCT00796302 - Treatment of Severe Childhood Aggression (The TOSCA Study) | Biotech Hunter | Biotech Hunter